» Articles » PMID: 17984111

Impaired Repair of Cyclobutane Pyrimidine Dimers in Human Keratinocytes Deficient in P53 and P63

Overview
Journal Carcinogenesis
Specialty Oncology
Date 2007 Nov 7
PMID 17984111
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

While many p53-deficient cell types are impaired in global genomic nucleotide excision repair of cyclobutane pyrimidine dimers (CPDs), human epidermal keratinocytes expressing human papillomavirus type 16 E6 and E7 are p53 deficient and yet maintain repair of CPD. We hypothesized that the p53 homolog, p63, may participate in governing global repair instead of p53 in keratinocytes. Following ultraviolet radiation (UVR) of E6/E7 keratinocytes, depletion of p63 but not of p73 impaired global genomic repair of CPD relative to control cells. In all cases, repair of pyrimidine(6-4)pyrimidone photoproducts, the other major UVR-induced DNA lesions, was unaffected. In E6/E7 keratinocytes treated with p63 small interfering RNA, reduced global repair of CPD was associated not with reduced levels of messenger RNA-encoding DNA damage recognition proteins but rather with decreased levels of DDB2 and XPC proteins, suggesting that p63 posttranscriptionally regulates levels of these proteins. These results indicate that global repair may be regulated at multiple levels and suggest a novel role for p63 in modulating repair of DNA damage in human keratinocytes. The results may provide insight into mechanisms of genomic stability in epithelia infected with oncogenic human papilloma viruses and may further explain the lack of increased skin cancer incidence in Li-Fraumeni syndrome.

Citing Articles

The dual role of p63 in cancer.

Xu Y, Yang X, Xiong Q, Han J, Zhu Q Front Oncol. 2023; 13:1116061.

PMID: 37182132 PMC: 10174455. DOI: 10.3389/fonc.2023.1116061.


Reduction of DNA damage repair efficiency and accumulation of residual damage following chronic UVB-irradiation of HaCaT cells.

Dorr M, Rochette P PLoS One. 2023; 18(4):e0283572.

PMID: 37027425 PMC: 10081739. DOI: 10.1371/journal.pone.0283572.


Xeroderma Pigmentosum C: A Valuable Tool to Decipher the Signaling Pathways in Skin Cancers.

Nasrallah A, Fayyad N, Kobaisi F, Badran B, Fayyad-Kazan H, Fayyad-Kazan M Oxid Med Cell Longev. 2021; 2021:6689403.

PMID: 34630850 PMC: 8495593. DOI: 10.1155/2021/6689403.


Signaling Pathways, Chemical and Biological Modulators of Nucleotide Excision Repair: The Faithful Shield against UV Genotoxicity.

Kobaisi F, Fayyad N, Rezvani H, Fayyad-Kazan M, Sulpice E, Badran B Oxid Med Cell Longev. 2019; 2019:4654206.

PMID: 31485292 PMC: 6702832. DOI: 10.1155/2019/4654206.


The interplay of UV and cutaneous papillomavirus infection in skin cancer development.

Hasche D, Stephan S, Braspenning-Wesch I, Mikulec J, Niebler M, Grone H PLoS Pathog. 2017; 13(11):e1006723.

PMID: 29190285 PMC: 5708609. DOI: 10.1371/journal.ppat.1006723.


References
1.
Barbieri C, Barton C, Pietenpol J . Delta Np63 alpha expression is regulated by the phosphoinositide 3-kinase pathway. J Biol Chem. 2003; 278(51):51408-14. DOI: 10.1074/jbc.M309943200. View

2.
Chen X, Zhang J, Lee J, Lin P, Ford J, Zheng N . A kinase-independent function of c-Abl in promoting proteolytic destruction of damaged DNA binding proteins. Mol Cell. 2006; 22(4):489-99. DOI: 10.1016/j.molcel.2006.04.021. View

3.
Marchbank A, Su L, Walsh P, DeGregori J, Penheiter K, Grayson T . The CUSP DeltaNp63alpha isoform of human p63 is downregulated by solar-simulated ultraviolet radiation. J Dermatol Sci. 2003; 32(1):71-4. DOI: 10.1016/s0923-1811(03)00040-9. View

4.
Okada Y, Osada M, Kurata S, Sato S, Aisaki K, Kageyama Y . p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation. Exp Cell Res. 2002; 276(2):194-200. DOI: 10.1006/excr.2002.5535. View

5.
Brunner H, Hamel B, van Bokhoven H . The p63 gene in EEC and other syndromes. J Med Genet. 2002; 39(6):377-81. PMC: 1735150. DOI: 10.1136/jmg.39.6.377. View